UiPath Inc (PATH) Options

what a mystified WS head fake, confused, drunken, stage 8 dementia carrying fox howlers can't read or interpret ER even on a early afternoon Thursday

PATH 10 Q due March 13

Should be a good ride here.

PATH new 52 week high

PATH new 52 week high

SHORT SQUEEEEEEEEEEZE. THANK YOU!

$4k profit before earnings. Thanks!

$4k profit before earnings. Thanks!

I guess I missed the bottom here. On watch.

https://stockcharts.com/h-sc/ui?s=path

I've had this one on my watchlist since they went public. We've been in an ever increasing risk-off environment for the last year and it's been a difficult environment for software start-ups. There has been some suspicion that their window to dominate this space is closing and the most recent guidance for growth was a short term deal killer.

I've liked their software since well before they went public but as we well know there's a graveyard full of great software the market killed off or was consumed by a market leader before they could mature and stand on their own.

I'm not predicting, just observing that this year and next may be a very rough road.

Seems over done here maybe putting in a Bottom Would like to see some new instution buying along with insider buying at most they would avg down here

Below is a chart of PATH since going public. It was massively overvalued initially and with inflation heating up the software industry is under pressure. See the 2nd pane of the chart for a relative strength chart comparing the SPX to the software industry.

For me, given the current environment, the valuation is still too high but others appear to disagree as it's found a bottom for now. NTM revenue is still ~18X, I'd be more comfortable @ 12X or $24-$25 a share as growth seems to be normalizing as they approach $1B a year in sales.

Q3 report notes from Barron's:

UiPath Tops Earnings and Sales Expectations. The Stock Falls.

Shares of UiPath fell Thursday after the robotic-process automation software company posted fiscal third-quarter results that were better than Wall Street expectations.

The stock dropped 1.6% to $46.93 after UiPath (ticker: PATH) reported adjusted earnings at break-even on a per-share basis on revenue of $220.8 million, up from year-earlier revenue of $147.3 million. The company’s annualized renewal run rate, or ARR, was $818.4 million, up 58%.

Analysts were expecting UiPath to report a loss of 4 cents a share on sales of $208.3 million and ARR of $798 million.

The net loss in the third quarter was $122.8 million, or 23 cents a share, compared with a year-earlier loss of $70.8 million, or 41 cents.

UiPath said it expects fourth-quarter revenue of $281 million to $283 million and ARR of $901 million to $903 million. Analysts are looking for fourth-quarter revenue of $281.5 million and ARR of $880 million.

Analysts at Oppenheimer maintained their Perform rating on UiPath shares, saying that while the company posted “robust backlog growth, and healthy operating margin improvements,” the “positives are somewhat offset by signs of the business decelerating and less optimistic ARR guidance, which implies further growth moderation.”

RBC Capital Markets maintained its Sector Perform rating and $55 price target. “Overall, we believe UiPath remains well-positioned as a long-term strategic enterprise automation vendor,” the analysts wrote in a research note.

KeyBanc analysts also said they see UiPath as the leading independent enterprise automation vendor. They reiterated their Overweight rating but lowered the price target to $69 from $86 “given higher interest rate/lower valuation environment.”

UiPath went public in April with an initial public offering price of $56 a share. The stock has fallen 12% over the past three months.

Q3 Earnings to be announced 12/8 after the market closes.

UiPath, Inc. (NYSE: PATH), a leading enterprise automation software company, today announced it will report financial results for its fiscal third quarter 2022 ended October 31, 2021 after the market close on Wednesday, December 8, 2021. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET.

UiPath Fiscal Third Quarter 2022 Financial Results Conference Call

When: Wednesday, December 8, 2021
Time: 5:00 pm ET
Conference ID: 13724511
Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll)

Replay: 1-877-660-6853 (US Toll-Free), 201-612-7415 (Toll)

(The replay will be available approximately two hours after the completion of the live call until 11:59 pm ET on December 22, 2021)
Webcast: https://ir.uipath.com

UiPath, Inc., (PATH), is the largest RPA, (Robotic Process Automation), company in the world. PATH engages in the development and provision of software platforms to automate business processes. It serves public, healthcare, telecommunication, finance, and banking industries. It offers accounts payable automation, claims processing automation, contact center automation, finance, and accounting automation.

PATH went public in April this year at $65, peaked at $90 in May, bottomed at $47 in October and has been moving up since then. It now trades above both its 20 and 50 day moving average and after a miserable six months is moving up just slightly more quickly than the average for the software industry.

The most positive thing I see is that accumulation has been moving up since late September. I started this board because I like the company. The valuation seems too high but if the technicals keep improving I'll invest.